Treatment successfully delivers drug across the blood-brain barrier directly to brain tumor in mice
- Glioblastoma currently has no cure. New treatments urgently needed
- Powerful drug is 1,400 times more potent than current treatment against the brain tumor
- Scientists applying to FDA for approval to test this novel treatment in patients with recurrent glioblastoma
One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can’t be used in patients because of two problems. First, it can’t reach its target because it’s blocked by the blood-brain barrier, a microscopic structure that protects the brain from toxins in the blood. And the conventional formulation for this drug is toxic to the brain.
But now Northwestern Medicine scientists have used a novel technology for opening the blood-brain barrier with an implantable ultrasound, and have delivered the powerful drug to the tumor in mice. In a new paper, they report on their findings of extensive preclinical research.
The scientists also discovered brain toxicity for the conventional formulation for this drug – paclitaxel -to the brain was caused by the solution required to dissolve the drug (cremophor.) Scientists tested a new formulation of the drug that uses albumin as opposed to cremophor, and it was not harmful to the brain.
Opening of the blood-brain barrier with an ultrasound increased the concentrations of this paclitaxel in the brain by five-fold. The study also showed that the brain tumor-bearing mice live much longer when treated with the powerful cancer-fighting drug paclitaxel, and survival was even further extended when treated in combination with ultrasound to open the blood-brain barrier.
The study will be published Dec. 12 in Clinical Cancer Research, a journal of the American Association for Cancer Research.
In the laboratory, paclitaxel is much more potent than the currently used chemotherapy temozolomide. When paclitaxel was tested against the brain tumor in a dish outside an organism, a 1,400-fold lesser drug concentration was necessary to kill same number of tumor cells, compared to the conventional chemotherapy used for this cancer.
The scientists are now applying to the U.S. Food & Drug Administration to launch a clinical trial to test this concept of a new formulation of paclitaxel in combination with the novel ultrasound technology to open the blood-brain barrier in patients. The planned trial aims to determine if the treatment is safe, and if it prolongs survival of patients with brain cancer.
“Glioblastoma currently has no cure, and when the tumor recurs there are not many treatment options,” said the principal investigator for this study, Dr. Adam Sonabend, an assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. “We urgently need effective new treatments.”
The ultrasound technology may have broader benefits. “This ultrasound technology now will enable us to use many agents established in other cancers for patients with brain tumors,” said co-investigator Roger Stupp, chief of neuro-oncology and the Paul C. Bucy Professor of Neurological Surgery at Feinberg.
Other clinical trials are testing ultrasound-based opening of the blood brain barrier with various chemotherapy agents, but none are using such a potent drug as paclitaxel.
How does it work?
The tiny ultrasound would be implanted during surgery into a window in the skull that does not contain bone. It is used in combination with microscopic gas bubbles injected into the blood at the same time the ultrasound begins. When the bubbles hit the sound waves, these vibrate and mechanically disrupt the blood-brain barrier. The opening is immediate, allowing penetration of the drug molecules. The blood-brain barrier opening is reversible and lasts for several hours after the sonication. The ultrasound emitter remains in the skull for repeated delivery of the drug.
Go deeper with Bing News on:
- Dr David I. Wrighton March 21, 2020 at 1:19 pm
Wright David I. Dr. David, 68, of Saint Paul, died March 17, 2020 after a two-year valiant battle with glioblastoma brain cancer. He was born in Neenah, Wisconsin. He graduated from Northfield High ...
- Improved Prediction of Surgical Resectability in Patients with Glioblastoma using an Artificial Neural Networkon March 20, 2020 at 3:12 am
In managing a patient with glioblastoma (GBM), a surgeon must carefully consider whether sufficient tumour can be removed so that the patient can enjoy the benefits of decompression and cytoreduction, ...
- Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responseson March 20, 2020 at 3:11 am
The mode of action for oncolytic viruses (OVs) in cancer treatment is thought to depend on a direct initial cytotoxic effect against infected tumor cells and subsequent activation of immune cell ...
- Novocure Announces Optune Lua™ as the Brand Name for the NovoTTF-100L™ Systemon March 19, 2020 at 5:23 am
The addition of a suffix to the Optune brand name helps differentiate between Tumor Treating Fields delivery systems for the treatment of MPM, glioblastoma and future potential indications. About ...
- Anticancer gene therapy regimen confers survival benefit in recurrent glioblastomaon March 18, 2020 at 10:52 am
Continued VB-111 monotherapy priming after progression with bevacizumab combination treatment improved survival outcomes among patients with recurrent glioblastoma, according to results of a phase ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Direction-Specific Release from Capsules with Homogeneous or Janus Shells Using an Ultrasound Approachon March 21, 2020 at 7:20 pm
Find more information on the Altmetric Attention Score and how the score is calculated. A variety of approaches have been developed to release contents from capsules, including techniques that use ...
- Global carotid ultrasound imaging market is expected to grow with a healthy CAGR over the forecast period from 2019-2025on March 21, 2020 at 5:36 pm
New York, March 20, 2020 -- Reportlinker.com announces the release of the report "Carotid Ultrasound Imaging Market: Global Industry Analysis, Trends, Market Size, and.
- Global Ultrasound Gels Market Outlook to 2027 by Type, Product, End-user and Regionon March 19, 2020 at 5:52 pm
Dublin, March 19, 2020 -- The "Ultrasound Gels Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to.
- Brain ultrasound scanner could speed diagnosis of head injurieson March 19, 2020 at 1:06 am
Ultrasound scanning could be used to diagnose stroke victims faster, and may even one day be used to check the head injuries of sport stars while they are still on the field. Ultrasound produces ...
- Amanda Bynes Is Pregnant And Posted The Ultrasound On Instagramon March 17, 2020 at 8:13 pm
Are Amanda Bynes and Paul Michael Trolling the Internet? Amanda Bynes' Lawyer Claims That The Former Actress Is Seeking 'Mental Health' Treatment Congratulations to former child actress Amanda Bynes, ...